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Research
AbstrACt
Objective To determine whether adults with 
normoglycaemia, impaired fasting glucose (IFG) and 
diabetes differed according to the incidence, rate, length 
and primary reasons for hospital admission.
Design Retrospective cohort study.
setting Barwon Statistical Division, Geelong, Australia.
Participants Cohort included 971 men and 924 women, 
aged 20+ years, participating in the Geelong Osteoporosis 
Study. Glycaemic status was assessed at cohort entry 
using fasting plasma glucose, use of antihyperglycaemic 
medication and/or self-report.
Primary and secondary outcome measures Primary 
outcome measure was any admission to the major tertiary 
public hospital in the study region over the follow-up 
period. Secondary outcome measures were admission rate 
and length (days).
results Over a median follow-up of 7.4 years (IQR 
5.3–9.6), participants with diabetes, compared with those 
with normoglycaemia, were two times as likely to be 
hospitalised (OR 2.07, 95% CI 1.42 to 3.02), had a higher 
admission rate (incidence rate ratio 1.61, 95% CI 1.17 to 
2.23) and longer hospital stay (third quartile difference 7.7, 
95% CI 1.3 to 14.1 and ninth decile difference 16.2, 95% CI 
4.2 to 28.3). IFG group was similar to normoglycaemia for 
the incidence, rate and length of admission. Cardiovascular 
disease-related diagnoses were the most common primary 
reasons for hospitalisation across all glycaemic categories.
Conclusions Our results show increased incidence, rate 
and length of all-cause hospital admission in adults with 
diabetes as compared with normoglycaemia; however, 
we did not detect any associations for IFG. Interventions 
should focus on preventing IFG-to-diabetes progression 
and reducing cardiovascular risk in IFG and diabetes.
IntrODuCtIOn  
The rapid increase in the prevalence of 
diabetes mellitus poses a significant challenge 
for health planners globally. Diabetes causes 
deterioration in physical health, mental 
well-being and quality of life, resulting in 
adverse outcomes including increased risk of 
hospitalisation.1 2 According to the Australian 
Institute of Health and Welfare (AIHW), 
diabetes is one of the major causes of 
Potentially Preventable Hospitalisations 
in Australia, where hospitalisation may be 
avoidable through timely and adequate 
non-hospital care.3–5 
It has been reported that people with 
diabetes have higher rates of hospitalisation 
as compared with those without the condi-
tion.6–9 Previous research, however, has 
mainly focused on individuals with a diag-
nosis of diabetes. The association of interme-
diate deteriorations in glucose metabolism 
such as impaired fasting glucose (IFG) and 
the risk of hospitalisation remains largely 
unexplored. IFG represents levels of fasting 
plasma glucose (FPG) that are above normal 
(100 mg/dL or 5.5 mmol/L) but below the 
diagnostic threshold for diabetes (126 mg/
dL or 7.0 mmol/L).1 IFG is known to increase 
the risk of cardiovascular disease in addition 
strengths and limitations of this study
 ► Retrospective cohort design with long-term 
follow-up.
 ► Randomly selected sample of general population, 
including both men and women.
 ► Robust method of identification of normoglycaemia, 
impaired fasting glucose and diabetes mellitus.
 ► To our knowledge, this is the first study to investi-
gate the relationship between impaired fasting glu-
cose and hospitalisation.
 ► Hospital admissions data were limited to the sole 
tertiary public hospital in the study region.
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to being a risk factor for diabetes.10 11 As evidence builds 
for IFG as a disease condition rather than just a risk factor 
for diabetes, investigating adverse outcomes including 
hospitalisations in this grouping is warranted. The aim 
of this study was to compare the incidence, rate and 
length of all-cause hospital admissions between adults 
with normoglycaemia, IFG and diabetes mellitus over a 
median period of 7.4 years. Moreover, we aimed to high-
light primary reasons for hospital admissions for individ-
uals in different glycaemic categories.
MethODs
study design and participants
We retrospectively analysed data from the Geelong Osteo-
porosis Study, a longitudinal cohort study including 3034 
residents of the Barwon Statistical Division (BSD), located 
in Southeastern Australia, with a population of around 
280 000. A detailed cohort profile, recruitment strategy 
and methodology have been described elsewhere.12 In 
brief, during 1993–1997, an age-stratified sample of 
1494 women aged 20–94 years was recruited from the 
Commonwealth electoral rolls with an overall participa-
tion of 77.1%. Of the original sample, 881 women partic-
ipated in the 10-year follow-up commencing 2004 and an 
additional 246 women aged 20–29 years were recruited in 
2006–2008. Of these two groups, we included 924 women 
for whom glycaemic status could be confirmed based on 
FPG measurement, self-reported diabetes and/or use of 
antihyperglycaemic agents.
Similarly, during 2001–2006, 1540 men were recruited 
and assessed, followed by a 5-year reassessment 
commencing 2006. We used either baseline or 5-year 
follow-up as the point of cohort entry depending on 
when FPG was measured. The final sample for this anal-
ysis included 971 men for whom we were able to ascer-
tain glycaemic status using FPG measurement, self-report 
and/or use of antihyperglycaemic agents. All participants 
provided informed consent.
baseline measures
Cohort entry or ‘baseline’ was defined as the point when 
glycaemic status was confirmed and the follow-up was 
up to 31 December 2012 or date of death where appli-
cable. At baseline, body weight and height were measured 
using electronic scales and a wall-mounted stadiometer, 
respectively. Venous blood was collected after an over-
night fast and FPG was measured using an adaptation 
of the hexokinase-glucose-6-phosphate dehydrogenase 
method.13 Participants were categorised into normogly-
caemia, IFG and diabetes according to the 2003 American 
Diabetes Association’s diagnostic criteria where diabetes 
was defined as FPG ≥7.0 mmol/L (126 mg/dL), self-re-
port of diabetes or use of antihyperglycaemic agents. 
IFG was considered present if FPG level was between 5.5 
and 6.9 mmol/L (100–125 mg/dL). Participants with a 
FPG level ≤5.5 mmol/L in the absence of self-reported 
diabetes or use of antihyperglycaemic agents were classi-
fied as having normoglycaemia.
A series of questionnaires was administered seeking 
information on sociodemographic characteristics, use of 
medications and supplements, physical activity, alcohol 
consumption, and cigarette smoking.12
Levels of physical activity were determined using a 
multiple choice question with responses ranging from 
‘very active and active’ (aggregated as ‘high mobility’) 
to ‘sedentary, limited, inactive, chair/bedridden and 
bedfast’ (aggregated as ‘low mobility’). Frequency of 
alcohol consumption was measured using the Cancer 
Council Victoria Dietary Questionnaire for Epidemio-
logical Studies.14 The Australian National Health and 
Medical Research Council guidelines were used to clas-
sify alcohol consumption into a binary variable; ‘low 
use’ (≤2 standard drinks/day) and ‘high use’ (>2 stan-
dard drinks/day), where a standard drink equals 10 g of 
alcohol.15 The Australian Bureau of Statistics Index of 
Relative Socioeconomic Advantage and Disadvantage was 
derived from the participants’ area of residence, as an 
indicator of socioeconomic status.16
Outcome measures
Our primary outcome measure was any hospital admis-
sion, planned or unplanned, to the University Hospital 
Geelong (UHG) during the follow-up period; women 
(median follow-up of 7.1 years, IQR 5.7–8.5) and men 
(median follow-up of 8.3 years, IQR 5.6–11.0). Secondary 
outcomes included admission rate based on the total 
number of hospital admissions over the follow-up period 
and length of admission in days, calculated from the 
admission and discharge dates, considering each admis-
sion as a separate occasion. Baseline data were linked to 
the admissions data using unique identification codes 
used by the hospital, referred to as Unit Record numbers.
The UHG is the largest public hospital and the sole 
health service in the study region classified as a ‘principal 
referral hospital’ according to the Australian hospitals 
peer-group classification.17 It has 370 inpatient beds, 24 
intensive care unit beds and had the only 24 hours Emer-
gency Department in the region during the study period. 
It provides a full spectrum of care, including community 
care, aged care, rehabilitation, mental health, emergency 
and acute care.18
Primary reasons for hospital admission
Australian hospitals use an alphanumeric coding system 
for diseases and external causes of injury, referred to as 
the 10th revision of the International Classification of 
Diseases, Australian Modification (ICD-10).19 It comprises 
three, four and five character categories, structured by 
body system and aetiology and is updated regularly.19 
We classified primary diagnoses into broad categories 
by aggregating individual disease codes, for instance, 
primary ICD-10 diagnoses codes of I21.0 ‘acute trans-
mural myocardial infarction (MI) of anterior wall’, I21.1 
‘acute transmural MI of inferior wall’ and I21.4 ‘acute 
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subendocardial MI’ were combined as a single category 
of I21 ‘acute MI’.
Deaths
All deaths during the follow-up period were confirmed 
using the National Death Index, a national register main-
tained by the AIHW containing records of all deaths 
registered in Australia since 1980.20 To identify deaths, a 
combination of surname, first and second given names, 
address, date of birth and date of last contact with the 
study were used.
Potential confounders
The risk of hospital admission in diabetes is reported 
to vary by age,4 sex,4 9 unhealthy weight,21 cigarette 
smoking,22 physical inactivity22 and socioeconomic depri-
vation.23 In addition, high alcohol use may cause difficul-
ties in management of diabetes, resulting in early onset 
of complications.23 Hence, we included these potential 
confounders in our analyses to investigate the relationship 
between glycaemic status and hospitalisation outcomes. 
Furthermore, due to previously reported differences in 
hospitalisation patterns between men and women with 
diabetes,4 9 we stratified our cohort by sex, in addition to 
reporting findings for the overall sample.
statistical analysis
We used t-tests for continuous data and χ2 tests for cate-
gorical data to compare baseline characteristics of partici-
pants in different glycaemic categories (normoglycaemia, 
IFG and diabetes).
For the analysis of association between glycaemic status 
and the incidence of all-cause hospital admission, χ2 test 
followed by incidence difference (ie, risk difference) and 
95% CIs have been reported for examining bivariate asso-
ciation (ie, the outcome and glycaemic status as exposure 
of interest). A set of trivariate analyses (ie, the outcome 
and glycaemic status as exposure of interest and one poten-
tial confounder) was performed to examine the impact of 
each potential risk factor above and beyond the glycaemic 
category association with the study outcomes. We used 
(1) trivariate logistic regressions for admission incidence, 
(2) trivariate Poisson regressions for admission rate and 
(3) two-way analyses of variance (ANOVAs) on rank of 
admission length. ORs, risk ratios and partial eta-squared 
effect size were used to illustrate the impact of poten-
tial risk factors, respectively. Partial eta-squared values 
of 0.009, 0.0588 and 0.1379 were considered as bench-
marks for small, medium and large effect sizes, respec-
tively.24 Multivariate logistic regression was performed 
to evaluate the association of admission incidence and 
glycaemic status after adjusting for potential confounders 
that were significant at 0.1 level in trivariate analyses and 
two-way interactions of confounders and glycaemic status; 
model-adjusted OR and 95% CI are reported. Admis-
sion rate was calculated as frequency of hospitalisation 
divided by total person-years of follow-up for normo-
glycaemia, IFG and diabetes groups. χ2 test followed by 
incidence rate ratio (IRR) and its 95% CI were illustrated 
for examining bivariate associations. Poisson regression 
with glycaemic status as factor and the frequency as the 
outcome and total person-years of follow-up as the offset 
was implemented for multivariate analysis. All potential 
confounders that were significant at 0.1 from the Poisson 
trivariate analyses were included in the primary multivar-
iate Poisson regression model. Sensitivity of the Poisson 
models against any deviations from model assumptions, 
including zero inflation was examined by implementing 
negative binomial regression models.
Medians and IQRs of admission length were reported 
in the three groups. In order to deal with positively 
skewed nature of admission length and possible outliers, 
a non-parametric median-based regression based on 
L1-norm estimation25 26 was performed as multivariate 
model. Simultaneous quantile regression on median, 
third quartile and ninth decile using bootstrapping tech-
nique for estimating SEs27 was used to analyse the rela-
tionship between glycaemic status and upper quartile 
and last decile of admission length. Similarly, all poten-
tial confounders that were significant at 0.1 from the 
two-way ranked ANOVAs were included in the primary 
multivariate linear regression model. Backward variable 
selection approach with P-entry=0.1 and P-exit=0.05 was 
implemented to all multivariate models obtain the final 
models.
Statistical analyses were conducted using Stata soft-
ware V.14 and Minitab statistical software package (V.17; 
Minitab, State College, Pennsylvania, USA).
results
Table 1 shows baseline characteristics of participants 
by glycaemic status. In men, 615 (63.3%) had normo-
glycaemia, 275 (28.3%) had IFG and 81 (8.3%) had 
diabetes. In women, 694 (75.1%) had normoglycaemia, 
159 (17.2%) had IFG and 71 (7.6%) had diabetes.
For both men and women, those with diabetes were 
older and had higher body mass index (BMI) as compared 
with normoglycaemia group. Women with diabetes were 
more likely to have ‘low mobility’ at baseline as compared 
with those with normoglycaemia. Participants with 
normoglycaemia, IFG and diabetes did not differ signifi-
cantly at baseline in terms of current smoking status and 
socioeconomic status.
Incidence of all-cause hospital admission (admission 
incidence)
Bivariate analyses showed that men with IFG had 10% 
more admission incidence (risk difference 0.10, 95% CI 
0.02 to 0.17, P=0.006) and men with diabetes had almost 
40% more admission incidence (risk difference 0.28, 
95% CI 0.17 to 0.39, P<0.001), compared with men with 
normoglycaemia.
Similarly, women with IFG and diabetes were also more 
likely to be admitted as compared with normoglycaemia 
(risk difference 0.10, 95% CI 0.01 to 0.18, P=0.024) and 
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(risk difference 0.28, 95% CI 0.16 to 0.39, P<0.001), 
respectively.
After accounting for glycaemic category through trivar-
iate analyses for both men and women in the study, older 
age and lower socioeconomic status were associated with 
increased admission incidence (table 2). In addition, a 
higher BMI in men and low mobility in women were asso-
ciated with increased admission incidence after adjusting 
for glycaemic category (table 2).
A significant age–sex interaction was observed and, 
therefore, included in the multivariate models (OR 1.3, 
95% CI 1.0 to 1.6, P=0.04). After adjustments for age, 
sex and socioeconomic status, participants with diabetes 
were twice likely to be hospitalised for any cause, as 
compared with normoglycaemia (OR 2.0, 95% CI 1.4 to 
3.0, P<0.001). Having IFG at baseline was not significantly 
associated with admission incidence (OR 1.1, 95% CI 0.8 
to 1.4, P=0.38).
Admission rate
Overall, 50.6% of the participants with diabetes were 
admitted more than once over the follow-up period, 
compared with 30.8% and 22.0% of those with IFG and 
normoglycaemia, respectively. In men, admission rate was 
0.43 per person per year for those with diabetes (95% CI 
0.32 to 0.57), 0.21 per person per year in IFG (95% CI 
0.17 to 0.27) and 0.19 per person per year in those with 
normoglycaemia (95% CI 0.15 to 0.23). Admission rate 
was 0.50 per person per year for women with diabetes 
(95% CI 0.30 to 0.84), 0.24 per person per year for those 
with IFG (95% CI 0.18 to 0.31) and 0.16 per person per 
year in those with normoglycaemia (95% CI 0.14 to 0.19). 
In men, older age, BMI, high alcohol use, low mobility 
and low socioeconomic status were associated with higher 
admission rate (table 2). In women, older age, high 
alcohol use and low mobility were associated with higher 
admission rate (table 2).
Table 1 Descriptive statistics of men and women at baseline by glycaemic status (normoglycaemia, IFG and diabetes) 
Men
Total
(n=971)
Normoglycaemia
(n=615)
IFG
(n=275)
Diabetes
(n=81) P value
Age (years) 56.9 (28.0–84.0) 52.0 (24.0–80.0) 62.0 (40.0–84.0) 67.0 (53.0–81.0) <0.001
BMI 26.9 (21.9–31.9) 26.3 (21.6–31.0) 28.0 (23.1–32.9) 28.6 (24.3–32.9) <0.001
Current smoking 141 (14.5) 98 (15.9) 33 (12.0) 10 (12.3) 0.25
High alcohol use 233 (23.9) 138 (22.4) 82 (29.8) 13 (16.0) 0.008
Low mobility 292 (30.0) 180 (29.2) 85 (30.9) 27 (33.3) 0.7
IRSAD
  1 166 (17.0) 96 (15.6) 49 9 (17.8) 21 (25.9) 0.39
  2 204 (21.0) 126 (20.4) 59 (21.4) 19 (23.4)
  3 189 (19.4) 126 (20.4) 52 (18.9) 11 (13.5)
  4 201 (20.7) 131 (21.3) 58 (21.0) 12 (14.8)
  5 211 (21.7) 136 (22.1) 57 (20.7) 18 (22.2)
Person-years of follow-up 7324.0 4644.1 2113.6 617.7
Women
Total
(n=924)
Normoglycaemia 
(n=694)
IFG
(n=159)
Diabetes
(n=71) P value
Age (years) 53.0 (25.0–81.0) 49.0 (20.0–78.0) 63.0 (41.0–85.0) 66.0 (46.0–86.0) <0.001
BMI 26.3 (19.1–33.5) 25.6 (19.3–31.9) 29.5 (22.3–36.7) 31.5 (21.4–41.6) <0.001
Current smoking 109 (11.7) 83 (11.9) 21 (13.2) 5 (7.0) 0.44
High alcohol use 55 (5.9) 45 (6.4) 9 (5.6) 1 (1.4) 0.24
Low mobility 202 (22.0) 121 (17.5) 48 (30.3) 33 (48.5) <0.001
IRSAD
  1 150 (16.2) 97 (13.9) 37 (23.2) 16 (22.5) 0.41
  2 186 (20.1) 145 (20.8) 30 (18.8) 11 (15.4)
  3 213 (23.0) 162 (23.3) 33 (20.7) 18 (25.3)
  4 187 (20.2) 141 (20.3) 32 (20.1) 14 (19.7)
  5 188 (20.3) 149 (21.4) 27 (16.9) 12 (16.9)
Person-years of follow-up 6434.1 4843.1 1104.4 486.6
Data presented as median (IQR) or n (%). Significant p values (p<0.05) are shown in bold. 
BMI, body mass index; IFG, impaired fasting glucose; IRSAD, Index of Relative Socioeconomic Advantage and Disadvantage.
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In the final multivariate model, admission rate was 
significantly higher in the diabetes group, as compared 
with normoglycaemia (IRR 1.6, 95% CI 1.1 to 2.2, 
P<0.05). The IFG group was not significantly different 
from normoglycaemia in terms of admission rate (IRR 
0.9, 95% CI 0.7 to 1.1, P=0.67).
Admission length (days)
The effect sizes of individual baseline characteristics on 
admission length based on two-way ranked ANOVA are 
illustrated in table 2. For men, older age, higher BMI and 
lower socioeconomic status were associated with increased 
admission length (table 2). Older age had a large effect 
on admission length, while high BMI and low socioeco-
nomic status had medium and small effects, respectively 
(partial eta squared=0.160, 0.011 and 0.007) (table 2).
Median regression analysis did not show a difference 
between the glycaemic categories in terms of median 
admission length (table 3). In additional analysis, third 
quartile and ninth decile comparison was performed 
showing that having diabetes at baseline was associated 
with an increased admission length (third quartile differ-
ence 7.7, 95% CI 1.3 to 14.1, P=0.01) and (ninth decile 
difference 16.2, 95% CI 4.2 to 28.3, P=0.008) in patients 
with longer than median admission length. Hence, in 
participants who spent longer than the median admission 
length in the hospital, having diabetes was associated with 
longer hospital stay.
Primary reasons for hospital admission
Figures 1 and 2 show the 10 most common primary 
reasons for hospitalisation by glycaemic category for men 
and women in the study, respectively.
Among men with diabetes, the most commonly encoun-
tered diagnosis was ‘angina pectoris’, with 20.0% of the 
group having at least one hospitalisation primarily for the 
condition. It was followed by ‘type 2 diabetes mellitus’ 
(14.5%). ‘Pain in throat and chest’ was the most common 
reason for hospitalisation for men in the IFG (14.6%) 
and normoglycaemia (9.8%) groups.
In women with diabetes, ‘type 2 diabetes mellitus’ 
was the most commonly documented primary reason 
for hospitalisation (12.5%), followed by ‘heart failure’ 
(10.4%). For the IFG and normoglycaemia groups, ‘pain 
in throat and chest’ was the most common reason for 
hospitalisation, 11.4% and 11.6%, respectively.
DIsCussIOn
This study reports that, compared with normoglycaemia, 
having diabetes is associated with a higher incidence, rate 
and length of hospital admission. During the follow-up, 
68.0% of participants with diabetes had at least one hospital 
admission as compared with 50.0% with IFG and 40.0% 
with normoglycaemia. The incidence of hospital admis-
sion was two times in those with diabetes as compared with 
normoglycaemia. Previous studies reporting admission 
incidence have varied depending on the study population 
and duration of follow-up. Only one study in the literature 
has examined hospitalisations in the Australian popula-
tion with diabetes.28 The study followed individuals aged 
45 years and over, with and without diabetes, for a year, 
reporting that 32.8% of participants with diabetes had 
one or more hospitalisations as compared with 24.2% of 
those with normoglycaemia.28 Similar studies have been 
performed in other countries, for example, a New Zealand 
study conducted over a 3-year period reported an all-cause 
hospitalisation rate of 43.5% in those with diabetes.29 An 
Italian study showed an even higher proportion of partic-
ipants with diabetes (55.0%) being hospitalised at least 
once over a 4.5-year follow-up.7
There are a number of factors which could explain 
the higher risk of hospitalisation in people with diabetes. 
Comorbid coronary heart disease, stroke, depression, 
musculoskeletal disease and cancer are common in 
people with diabetes and can increase the risk of hospi-
talisation.30 31 In addition, diabetes shares common risk 
factors with other chronic diseases (particularly cardio-
vascular disease) such as obesity, physical inactivity and 
unhealthy diet. In our study, half of the 10 most common 
primary reasons for hospitalisation in participants with 
diabetes were related to complications and/or diagnoses 
related to cardiovascular disease. This is consistent with 
studies showing that a significant proportion of morbidity 
and mortality associated with diabetes is due to cardio-
vascular disease.10 Some recent studies have reported a 
decline in incident cardiovascular disease in people with 
diabetes; however, the risk is still double that of those with 
normoglycaemia.32
In our sample, older age was independently associ-
ated with both having diabetes and the risk of hospital-
isation. Elderly patients with diabetes often present with 
multiple and advanced complications and are more likely 
to be readmitted and spend longer in hospital beds as 
compared with younger counterparts.33
Other factors predisposing people with diabetes to 
hospitalisation are related to disease management that 
involves maintaining a balance between lowering blood 
glucose levels and preventing hypoglycaemic events. One 
of the goals of management is achieving tight glycaemic 
control (FPG <6 mmol/L), while this has been shown to 
reduce microvascular complications, it may simultane-
ously increase the incidence of hypoglycaemic events.6 
Therefore, the benefits of obtaining optimum blood 
glucose levels have to be weighed against the risk of severe 
hypoglycaemic episodes that could result in frequent 
Emergency Department visits and hospital admissions.34 
Furthermore, optimal diabetes care requires active 
involvement by the patients and their ability to navigate 
the health system, hence, health literacy plays a key role. 
Health outcomes are poorer in population subgroups 
with diabetes having low health literacy levels such as 
migrants from non-English-speaking backgrounds and 
indigenous people.35 36
In our study, 14.5% of men and 12.5% of women with 
diabetes had a hospitalisation specifically for a diagnosis 
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or complication related to diabetes mellitus. Other studies 
have reported higher proportions of diabetes-related 
hospitalisations in the group with diabetes ranging from 
18.8% to 33.0% per year.6 9 28 29 This could be explained by 
the fact that our sample was derived from general popula-
tion which may be healthier than clinical samples used in 
other studies. It might also be a ‘healthy participant bias’ 
where individuals with less severe disease agree to partic-
ipate in research resulting in an underestimation of the 
outcome. It could also have resulted from not being able 
to capture admissions to private hospitals and smaller 
hospitals in the study region. Furthermore, definitions of 
diabetes-related hospitalisations are inconsistent between 
countries and thus, comparisons need to be made 
cautiously. In Australia, diabetes coding standards have 
changed significantly over the last decade making it prob-
lematic to compare diabetes-related hospitalisation rates 
over time.4 Nonetheless, our results highlight an opportu-
nity to devise interventions aimed specifically at reducing 
or delaying complications in those with diabetes. Previous 
evidence suggests that microvascular complications can 
be reduced by up to 50%–60% and macrovascular compli-
cations by 40%–45% with improved outpatient manage-
ment.9 The Diabetes Control and Complications Trial 
demonstrated that intensive diabetes treatment delayed 
the onset of complications in adolescents and young 
adults with type 1 diabetes mellitus.34 The trial concluded 
that intensive therapy aimed at achieving non-diabetic 
glucose levels slowed the progression of diabetic reti-
nopathy, nephropathy and neuropathy.34 Similarly, the 
United Kingdom Prospective Diabetes Study showed a 
substantial decrease in microvascular complications of 
type 2 diabetes through intensive blood glucose control37 
and Steno study showed reduced rates of cardiovascu-
lar-related mortality with multifactorial intervention.38
We did not detect an association between IFG and the 
incidence, rate and length of hospital admission. To our 
knowledge, this is the first study to investigate the relation-
ship between IFG and hospitalisation, thus, comparable 
data are not available. Studies have reported a moderate 
increase in the risk of cardiovascular disease in the ‘predi-
abetes’ group as compared with normoglycaemia, which 
increases significantly once diabetes develops.39 Current 
rates of IFG-to-diabetes progression are alarmingly high, 
with studies reporting development of diabetes in up to 
two-thirds of individuals with prediabetes.39 The authors 
of this study have previously reported that approximately 
one-third of Australian women have IFG, with a sixfold 
higher risk of progressing to diabetes over a decade 
if FPG ≥6.1 mmol/L.11 The greatest reductions in the 
occurrence of diabetes have been achieved through 
intensive lifestyle interventions for weight loss (5%–10% 
of body weight), dietary modification and physical activity 
(~30 min/day).39 Pharmacological therapy such as 
metformin has also shown some promise, particularly in 
the younger and obese individuals.40 Our findings show 
that the incidence of hospital admission multiplies as IFG 
progresses to diabetes, which if used effectively in public 
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health campaigns, could help reduce progression in the 
population.
This study has a number of distinct advantages over 
previous studies that have explored the relationship 
between diabetes and hospital admissions. Our sample 
comprised randomly selected community-dwelling adults 
living in a well-defined area. Previous studies have used 
self-report,28 hospital admissions data,9 29 41 general practice 
registers6 42 or data from diabetes clinics7 to identify individ-
uals with diabetes. We used a more robust method for iden-
tifying diabetes using a combination of FPG measurement, 
self-report and/or use of antihyperglycaemic medication. 
Through this approach, we were able to identify individ-
uals with dysglycaemia, even in the absence of fully devel-
oped diabetes. Furthermore, we followed participants for 
hospital admissions over a longer period as compared with 
previous studies.28 29 Finally, we used unique identifiers to 
capture hospital admissions and mortality data, hence, we 
were able to obtain this information even if we lost contact 
with participants over the study period. Our study has some 
limitations. First, we obtained linked hospital admissions 
data from one major public hospital in the study region. 
It is possible that some of our participants were admitted 
to a private hospital or a smaller hospital. We consider this 
Figure 1 Primary reasons for hospital admission by glycaemic category (percentage of men).
Figure 2 Primary reasons for hospital admission by glycaemic category (percentage of women).
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Open Access 
unlikely as UHG is the only major tertiary hospital in the 
study area and our sample was derived from a region in the 
immediate vicinity of the hospital. Second, although our 
study region (BSD) is considered to have a stable popula-
tion, it is still possible that some of the participants might 
have moved intercity or interstate during the follow-up 
period. Furthermore, the results from our study, which 
included mainly Caucasian individuals, may not be general-
isable to other populations. Finally, we did not differentiate 
between the types of diabetes at baseline and are, therefore, 
unable to comment on the proportion of different types of 
diabetes in our sample.
COnClusIOn
Our study confirms existing evidence showing higher 
incidence, rate and length of hospital admissions in indi-
viduals with diabetes mellitus. Further research should 
focus on identifying individual risk factors for hospital-
isation in dysglycaemia. Strategies to reduce the need 
for hospitalisation should include preventing the disease 
itself (primary prevention), early diagnosis and treat-
ment (secondary prevention) and preventing compli-
cations (tertiary prevention). Finally, adverse outcomes 
related with diabetes including hospital admissions could 
be reduced by preventing the progression from IFG to 
diabetes. We recommend screening for IFG in the popu-
lation combined with targeted interventions to prevent 
diabetes in high-risk individuals.
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